4
Changes in Ownership
Dermata Therapeutics, Inc. Filed Acc 0000905718-22-000052
Options or other derivatives
- Senior VP, Development acquired 30,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Nardo Christopher J. · Senior VP, Development
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-01-03 | Grant or award : show line 1 in the form Stock Option (right to buy) | +30,000 | 30,000 | D |
Loading xslF345X03/dermata_fm4jan32022.xml…